Upright MRI for Prostate Cancer Screening identifier:
NCT03474913 (

Screening for prostate cancer using upright MRI

Study Contact Information:

For additional information, please contact:

Study Director: Dara Lundon (212) 241-0751  [email protected]


About the Study

This study will compare the effectiveness of an upright magnetic resonance imaging (MRI) compared to prostate specific antigen (PSA) and current MRI imaging for prostate cancer screening.

What the Study Involves

Participants will have a standard of care MRI as well as an upright, seated MRI. After each MRI, participants will be asked to fill out questionnaires to assess their comfort level during the scans. If something suspicious is found on either scan, participants may have an ultrasound guided biopsy of the prostate, a way to sample and test prostate tissue for cancer. Researchers will check in with the participants every 6 months for 5 years.

Study Site

New York

New York
Icahn School of Medicine at Mount Sinai
Principal Investigator: Ash Tewari, MD  
Contact: Dara Lundon (212) 241-0751 [email protected]

Lead Researcher

Ash Tewari: Icahn School of Medicine at Mount Sinai

This Study is Open To:

Men 18 years and older who: 

This Study is Not Open To:

Those who do not meet the criteria defined above and individuals who: 


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.